FDA issued a Warning Letter to Glenmark Pharmaceuticals Limited on 10/3/2019 as a result of this inspection.
FDA investigators audited the Glenmark Pharmaceuticals - Solan, India facility and issued inspectional observations (via FDA 483) on 20 Apr 2019.
Product details
- Category: Human Drugs
- Inspection end: 20 Apr 2019
- Location: Solan, India
- FEI: 3005757050
